Cargando…

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

Hydroxychloroquine (HCQ) has been largely used and investigated as therapy for COVID-19 across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (total 2400 mg over 5 days) was recommended for hospitalised patients with COVID-19. We c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catteau, Lucy, Dauby, Nicolas, Montourcy, Marion, Bottieau, Emmanuel, Hautekiet, Joris, Goetghebeur, Els, van Ierssel, Sabrina, Duysburgh, Els, Van Oyen, Herman, Wyndham-Thomas, Chloé, Van Beckhoven, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444610/ https://www.ncbi.nlm.nih.gov/pubmed/32853673 http://dx.doi.org/10.1016/j.ijantimicag.2020.106144

Ejemplares similares

Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”
por: Dauby, Nicolas, et al.
Publicado: (2021)

Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
por: Dauby, N., et al.
Publicado: (2021)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021)

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
por: Stouten, Veerle, et al.
Publicado: (2022)

The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
por: Taccone, Fabio Silvio, et al.
Publicado: (2020)

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
por: Braeye, Toon, et al.
Publicado: (2023)

Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort
por: Van Beckhoven, D, et al.
Publicado: (2020)

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
por: Van Goethem, Nina, et al.
Publicado: (2021)

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021
por: Braeye, Toon, et al.
Publicado: (2022)

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
por: Braeye, Toon, et al.
Publicado: (2023)

Un cadre conceptuel pour étudier la relation de causalité entre des variants du SARS-CoV-2 et la sévérité de la COVID-19 chez les patients hospitalisés
por: Van Goethem, N., et al.
Publicado: (2022)

Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples
por: Romanko, Aleksandr A., et al.
Publicado: (2023)

The genetic structure of the Belgian population
por: Van den Eynden, Jimmy, et al.
Publicado: (2018)

Evaluating hospital performance based on excess cause-specific incidence
por: Van Rompaye, Bart, et al.
Publicado: (2015)

Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021
por: Braeye, Toon, et al.
Publicado: (2021)

Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies
por: Fischer, Natalie, et al.
Publicado: (2021)

Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium
por: Erazo, Diana, et al.
Publicado: (2022)

Simulation of between Repeat Variability in Real Time PCR Reactions
por: Lievens, Antoon, et al.
Publicado: (2012)

Healthcare-associated infections in home healthcare: an extensive assessment, 2019
por: Hoxha, Ana, et al.
Publicado: (2021)

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium
por: Peñalvo, José L., et al.
Publicado: (2021)

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
por: Faes, Christel, et al.
Publicado: (2020)

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data
por: Meurisse, Marjan, et al.
Publicado: (2022)

Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
por: Meurisse, Marjan, et al.
Publicado: (2023)

The Importance of Integrating Clinical Relevance and Statistical Significance in the Assessment of Quality of Care –Illustrated Using the Swedish Stroke Register
por: Lindmark, Anita, et al.
Publicado: (2016)

Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study
por: Klamer, Sofieke, et al.
Publicado: (2021)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2022)

Impact of variance components on reliability of absolute quantification using digital PCR
por: Jacobs, Bart KM, et al.
Publicado: (2014)

Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2020)

Correction to: Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2021)

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care
por: Van Beckhoven, Dominique, et al.
Publicado: (2022)

Implications of covariate induced test dependence on the diagnostic accuracy of latent class analysis in pulmonary tuberculosis
por: Keter, Alfred Kipyegon, et al.
Publicado: (2022)

On shrinkage and model extrapolation in the evaluation of clinical center performance
por: Varewyck, Machteld, et al.
Publicado: (2014)

On the practice of ignoring center‐patient interactions in evaluating hospital performance
por: Varewyck, Machteld, et al.
Publicado: (2015)

Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
por: Kalligeros, Markos, et al.
Publicado: (2020)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments
por: Fischer, Krista, et al.
Publicado: (2011)

Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification
por: Olsen, Maria, et al.
Publicado: (2021)

Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
por: Leclercq, Victoria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l73hf3vumk3vd57uosdkaalrjc